CONFIDENTIAL TREATMENT REQUEST FIRST AMENDMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • September 29th, 2008 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This FIRST AMENDMENT (this “Amendment”) is made effective as of 27 June 2008 (the “Amendment Effective Date”), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation having an address of Cedar Brook Corporate Center, 4C Cedar Brook Drive, Cranbury, New Jersey 08512 (“Palatin”) and ASTRAZENECA AB, a company incorporated in Sweden under no. 556011-7482 with offices at S-151 85 Södertälje, Sweden (“AstraZeneca”).
